FILE PHOTO: Sierk Poetting, CFO of German biotech firm BioNTech, is interviewed by journalists in Marburg, Germany September 17, 2020. REUTERS/Fabian BimmerBERLIN: German COVID-19 vaccine maker BioNtech is open to further capacity expansion and the construction of new production facilities depending on demand, Chief Financial Officer Sierk Poetting said.
"There is still room for improvement. But that will ultimately also depend on demand," Poetting said in an interview with the Handelsblatt newspaper published on Wednesday.Poetting said if premises were available, BioNtech could build up additional production capacity in six months, adding that discussions were ongoing.The Mainz-based biotech company and its US partner Pfizer plan to produce 2.5 billion COVID-19 doses this year, of which 1.4 billion were already sold.
BioNTech in February launched production at its new site in the city of Marburg, which it purchased from Novartis last year, raising its annual capacity by around 1 billion doses.
21.4.2021 Myanmar military his aspiring people cut-throat located overkiller man
Tell us about the Moderna vaccine.
Singapore Latest News, Singapore Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.